FBXW5 and Parkinson disease: Previous work has shown that TIPE1/Oxi-beta can competitively bind to FBXW5 with tuberous sclerosis complex 2 (TSC2), increasing the stability of TSC2 and promoting excessive autophagy in Parkinson’s disease [28].